HIV trials recruiting in District of Columbia

All HIV trials nationally

Cities in District of Columbia

Recruiting trials in District of Columbia

• A Clinical Study of Islatravir and Ulonivirine for People With HIV-1 Who Have Not Been Treated Before (MK-8591B-062)
  NCT07266831 · Phase: Phase 2, Phase 3 · Ages: 18 Years and older · Sex: All (male and female) · District of Columbia: Washington D.C.
• A Clinical Study of MK-8527 to Prevent Human Immunodeficiency Virus Type 1 (HIV-1) (MK-8527-011)
  NCT07044297 · Phase: Phase 3 · Ages: 16 Years and older · Sex: All (male and female) · District of Columbia: Washington D.C.
• A Clinical Trial of Combination HIV-Specific Broadly Neutralizing Monoclonal Antibodies Combined With ART Initiation During Acute HIV Infection to Induce HIV Remission
  NCT05719441 · Phase: Phase 2 · Ages: 18 Years to 70 Years · Sex: All (male and female) · District of Columbia: Washington D.C.
• A Study to Investigate Cabotegravir Ultra Long-Acting (CAB ULA) Plus Rilpivirine Ultra Long-Acting (RPV ULA) in Adults and Adolescents With HIV Who Are Virologically Suppressed
  NCT07650916 · Phase: Phase 3 · Ages: 12 Years and older · Sex: All (male and female) · District of Columbia: Washington D.C.
• Collecting Blood and Tissue Sample Donations for Research for HIV/AIDS-Related Cancers
  NCT05663502 · Phase: Not specified · Ages: 18 Years and older · Sex: All (male and female) · District of Columbia: Washington D.C.
• Comparing Mobile Health Strategies to Improve Pre-exposure Prophylaxis Use (PrEP) for HIV Prevention
  NCT04855773 · Phase: Not applicable (e.g. observational or device study) · Ages: 15 Years and older · Sex: All (male and female) · District of Columbia: Washington D.C.
• Durvalumab and Tremelimumab in Combination With Chemotherapy in HIV-infected Patients With Non-small Cell Lung Cancer
  NCT04499053 · Phase: Phase 2 · Ages: 18 Years and older · Sex: All (male and female) · District of Columbia: Washington D.C.
• Evaluating Gardasil HPV Vaccine Humoral and Cellular Immune Responses in People With and Without HIV
  NCT06624839 · Phase: Phase 2 · Ages: 18 Years to 70 Years · Sex: Male · District of Columbia: Washington D.C.
• Evaluation Of Semaglutide in Adults With Cocaine Use Disorder With and Without HIV
  NCT06691243 · Phase: Phase 2 · Ages: 18 Years to 65 Years · Sex: All (male and female) · District of Columbia: Washington D.C.
• Impact of Behavior Modification Interventions and Lung Cancer Screening on Smoking Cessation in People Living With HIV: A Feasibility Study
  NCT04949464 · Phase: Not applicable (e.g. observational or device study) · Ages: 45 Years to 80 Years · Sex: All (male and female) · District of Columbia: Washington D.C.
• Intervention to Enhance PrEP Persistence
  NCT06872307 · Phase: Not applicable (e.g. observational or device study) · Ages: 18 Years and older · Sex: Male · District of Columbia: Washington D.C.
• Peer Behavioral Activation Utilization to Improve Substance Use and HIV Outcomes in People Receiving Long Acting Injectable-PrEP/ART (PUSH)
  NCT06501781 · Phase: Not applicable (e.g. observational or device study) · Ages: 18 Years to 88 Years · Sex: All (male and female) · District of Columbia: Washington D.C.
• Pharmacokinetics, Safety, Tolerability of Dolutegravir/Rilpivirine in Pediatrics
  NCT05674656 · Phase: Phase 1, Phase 2 · Ages: 6 Years to 12 Years · Sex: All (male and female) · District of Columbia: Washington D.C.
• Predictors of Health Service Utilizations Among Key Population in Washington DC
  NCT06046079 · Phase: Not specified · Ages: 18 Years and older · Sex: All (male and female) · District of Columbia: Washington D.C.
• Studies of the Pathogenesis of HIV Infection in Human Peripheral Blood Cells and/or Body Fluids in People Living With and Without HIV
  NCT00001281 · Phase: Not specified · Ages: 18 Years to 120 Years · Sex: All (male and female) · District of Columbia: Washington D.C.
• Study of GS-0415 and How It Works in People With HIV
  NCT07719491 · Phase: Phase 1 · Ages: 18 Years to 65 Years · Sex: All (male and female) · District of Columbia: Washington D.C.
• The DC Cohort Longitudinal HIV Status Neutral Study
  NCT01206920 · Phase: Not specified · Ages: No age limits stated · Sex: All (male and female) · District of Columbia: Washington D.C.